Profund Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.93M	Buy	81,743 +17,572	+27%	+$448K	0.07%	218
2025 Q4	$1.86M	Buy	64,171 +31,615	+97%	+$809K	0.06%	230
2025 Q3	$614K	Sell	32,556 -113	-0.3%	-$1.78K	0.02%	446
2025 Q2	$458K	Sell	32,669 -1,069	-3%	-$15K	0.02%	489
2025 Q1	$528K	Sell	33,738 -7,285	-18%	-$103K	0.02%	454
2024 Q4	$571K	Sell	41,023 -13,559	-25%	-$149K	0.02%	446
2024 Q3	$508K	Buy	54,582 +6,392	+13%	+$63.1K	0.02%	525
2024 Q2	$448K	Sell	48,190 -78,093	-62%	-$706K	0.02%	537
2024 Q1	$1.25M	Buy	+126,283	New	+$942K	0.05%	299
2023 Q4	–	Sell	-69,926	Closed	-$371K	–	1133
2023 Q3	$371K	Sell	69,926 -19,854	-22%	-$169K	0.02%	562
2023 Q2	$856K	Buy	89,780 +33,590	+60%	+$373K	0.05%	350
2023 Q1	$618K	Buy	+56,190	New	+$813K	0.04%	441